Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:e211-e219
Published online before print December 23, 2008, doi: 10.1161/CIRCULATIONAHA.108.792952
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
119/8/e211    most recent
CIRCULATIONAHA.108.792952v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nobuyoshi, M.
Right arrow Articles by Nosaka, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nobuyoshi, M.
Right arrow Articles by Nosaka, H.
Related Collections
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow Echocardiography

(Circulation. 2009;119:e211-e219.)
© 2009 American Heart Association, Inc.


Heart Disease in Asia

Percutaneous Balloon Mitral Valvuloplasty

A Review

Masakiyo Nobuyoshi, MD; Takeshi Arita, MD; Shin-ichi Shirai, MD; Naoya Hamasaki, MD; Hiroyoshi Yokoi, MD; Masashi Iwabuchi, MD; Hitoshi Yasumoto, MD; Hideyuki Nosaka, MD

From Kokura Memorial Hospital (M.N., T.A., S.S., H. Yokoi, M.I. H. Yasumoto, H.N.) and Hamasaki Cardiology Clinic (N.H.), Kitakyushu, Japan.

Correspondence to Masakiyo Nobuyoshi, MD, Department of Cardiology, Kokura Memorial Hospital, 1–1, Kifune-cho, Kokura-kitaku, Kitakyushu, Japan. E-mail kmhptca@kokura-heart.com


Key Words: balloon valvuloplasty • echocardioagraphy • mitral valve • mitral valve stenosis • rheumatic heart disease


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Several diseases have been acknowledged as pathological causes for mitral valve stenosis (MS), of which rheumatic heart disease is the most prevalent. Rheumatic heart disease is a chronic manifestation of rheumatic carditis, which occurs in 60% to 90% of cases of rheumatic fever. Rheumatic fever is a late sequela to Group A β-hemolytic streptococcal infection of the throat. The initial rheumatic fever results only in an edematous inflammatory process, leading to the fibrinoid necrosis of the connective tissue and cellular reactions. The initial valvulitis results in verruciform deposition of fibrin along the closing portion of the leaflets. Although all of the cardiac valves may be involved by this rheumatic process, the mitral valve is involved most prominently. The endocardial lesion most often leaves permanent sequela resulting in valvular regurgitation, stenosis, or both. Stenosis of this valve occurs from leaflet thickening, commissural fusion, and chordal shortening/fusion due to the above described pathological process.


*    Rheumatic Heart Valve Disease Is Still Epidemic in Asia
 
The decrease of the incidence of rheumatic heart disease in developed countries had already begun in 1910, and it is now below 1.0 per 100 000. On the other hand, the occurrence rate of rheumatic heart disease in developing countries remains substantial. Because the decline in the prevalence of rheumatic fever in industrialized nations started even before the era of penicillin and thus was related to improved living standards, the continued prevalence of rheumatic heart disease in undeveloped or developing countries is related not only to the limited availability of penicillin but to their socioeconomic status (ie, overpopulation, . . . [Full Text of this Article]